Scientist: Michele Cecchini

Michele Cecchini profileMichele Cecchini leads the work on public health at the OECD – the Organisation for Economic Co-operation and Development. Working at the intersection of health and economics, Michele’s team focuses on priority setting and programme evaluation of policies affecting population health, helping countries implement better public health policies for better lives.

The results of this work have fed into relevant policy-making activities at various levels, from national policy-making to intergovernmental dialogue at the G7, G20 and UN General Assembly high-level events on public health.

Michele’s work has also appeared in major academic journals such as the Lancet and the American Journal of Preventive Medicine.

Michele is an Adjunct Professor of Applied Health Economics at the School of Public Health, University of Siena, and has held a visiting position at the Duke-NUS Graduate Medical School in Singapore. Michele is a medical doctor specialised in public health and holds master’s degrees from the London School of Economics and the London School of Hygiene and Tropical Medicine and a PhD from Imperial College London.

Michele Cecchini interview: man using vape electronic cigarette e-cigarettes

A scientist’s opinion: interview with Dr Michele Cecchini on e-cigarettes and young people

Adjunct Professor and Medical Doctor Michele Cecchini leads the work on public health at the OECD - the Organisation for Economic Co-operation and Development, helping countries implement better public health policies for better lives. Based on your work with the Organisation for Economic Co-operation and Development (OECD), how do economic evaluations influence the development and ...

man using vape electronic cigarette e-cigarettes

Do e-cigarettes pose a growing threat to the health of young Europeans?

E-cigarettes tend to be particularly popular among younger people. But how dangerous are they? Modern electronic cigarettes (e-cigarettes) were introduced two decades ago, becoming commercially available in Europe and the USA around 2006. They were viewed as a potentially less harmful alternative to traditional tobacco products. However, while the long-term health effects remain unclear, other ...

European Science-Media Hub
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.